Journal Article DZNE-2023-00143

http://join2-wiki.gsi.de/foswiki/pub/Main/Artwork/join2_logo100x88.png
Serum IL-6, sAXL, and YKL-40 as systemic correlates of reduced brain structure and function in Alzheimer's disease: results from the DELCODE study.

 ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;

2023
BioMed Central London

Alzheimer's research & therapy 15(1), 13 () [10.1186/s13195-022-01118-0]

This record in other databases:    

Please use a persistent id in citations: doi:

Abstract: Neuroinflammation constitutes a pathological hallmark of Alzheimer's disease (AD). Still, it remains unresolved if peripheral inflammatory markers can be utilized for research purposes similar to blood-based beta-amyloid and neurodegeneration measures. We investigated experimental inflammation markers in serum and analyzed interrelations towards AD pathology features in a cohort with a focus on at-risk stages of AD.Data of 74 healthy controls (HC), 99 subjective cognitive decline (SCD), 75 mild cognitive impairment (MCI), 23 AD relatives, and 38 AD subjects were obtained from the DELCODE cohort. A panel of 20 serum biomarkers was determined using immunoassays. Analyses were adjusted for age, sex, APOE status, and body mass index and included correlations between serum and CSF marker levels and AD biomarker levels. Group-wise comparisons were based on screening diagnosis and routine AD biomarker-based schematics. Structural imaging data were combined into composite scores representing Braak stage regions and related to serum biomarker levels. The Preclinical Alzheimer's Cognitive Composite (PACC5) score was used to test for associations between the biomarkers and cognitive performance.Each experimental marker displayed an individual profile of interrelations to AD biomarkers, imaging, or cognition features. Serum-soluble AXL (sAXL), IL-6, and YKL-40 showed the most striking associations. Soluble AXL was significantly elevated in AD subjects with pathological CSF beta-amyloid/tau profile and negatively related to structural imaging and cognitive function. Serum IL-6 was negatively correlated to structural measures of Braak regions, without associations to corresponding IL-6 CSF levels or other AD features. Serum YKL-40 correlated most consistently to CSF AD biomarker profiles and showed the strongest negative relations to structure, but none to cognitive outcomes.Serum sAXL, IL-6, and YKL-40 relate to different AD features, including the degree of neuropathology and cognitive functioning. This may suggest that peripheral blood signatures correspond to specific stages of the disease. As serum markers did not reflect the corresponding CSF protein levels, our data highlight the need to interpret serum inflammatory markers depending on the respective protein's specific biology and cellular origin. These marker-specific differences will have to be considered to further define and interpret blood-based inflammatory profiles for AD research.

Keyword(s): Alzheimer Disease: blood (MeSH) ; Humans (MeSH) ; Alzheimer Disease: pathology (MeSH) ; Interleukin-6 (MeSH) ; Chitinase-3-Like Protein 1 (MeSH) ; Amyloid beta-Peptides (MeSH) ; Brain: pathology (MeSH) ; Cognitive Dysfunction: diagnosis (MeSH) ; Biomarkers (MeSH) ; tau Proteins (MeSH) ; Amyloid beta-Peptides: cerebrospinal fluid (MeSH) ; Biomarkers: blood (MeSH) ; Chitinase-3-Like Protein 1: blood (MeSH) ; Cognitive Dysfunction: blood (MeSH) ; Interleukin-6: blood (MeSH) ; tau Proteins: cerebrospinal fluid (MeSH) ; Alzheimer’s disease ; Alzheimer’s disease ; Biomarker ; Blood-based ; Cognition ; Inflammation ; Structural MRI ; Interleukin-6 ; Chitinase-3-Like Protein 1 ; Amyloid beta-Peptides ; Biomarkers ; tau Proteins ; AXL protein, human

Classification:

Contributing Institute(s):
  1. Interventional Trials and Biomarkers in Neurodegenerative Diseases (Biomarker)
  2. Multimodal Neuroimaging (AG Maaß)
  3. Neuropsychology (AG Wagner)
  4. Neuroinflammation, Biomarker (AG Heneka ; AG Heneka)
  5. Cell Biology of Neurological Diseases (AG Jucker)
  6. Vascular Pathology (AG Dirnagl)
  7. Translational Neuropsychiatry (AG Priller)
  8. Clinical Neurophysiology and Memory (AG Düzel)
  9. Interdisciplinary Dementia Research (AG Endres)
  10. Translational Dementia Research (Bonn) (AG Schneider)
  11. Patient Studies Bonn (Patient Studies Bonn)
  12. Epigenetics and Systems Medicine in Neurodegenerative Diseases (AG Fischer)
  13. Molecular biomarkers for predictive diagnostics of neurodegenerative diseases (AG Wiltfang)
  14. Vascular Cognitive Impairment & Post-Stroke Dementia (AG Dichgans)
  15. Clinical Dementia Research (Rostock /Greifswald) (AG Teipel)
  16. Parkinson Genetics (AG Gasser)
  17. Core KAP (Kooperationseinheit Angewandte Präventionsforschung) (Core Technical Staff)
  18. Molecular Neurobiology (AG Simons)
  19. Clinical Research Platform (CRP) (Clinical Research Platform (CRP))
  20. Innate Immunity in Neurodegeneration (AG Latz ; AG Latz)
  21. Clinical Alzheimer’s Disease Research (AG Jessen)
  22. Delcode (Delcode)
Research Program(s):
  1. 353 - Clinical and Health Care Research (POF4-353) (POF4-353)
  2. 352 - Disease Mechanisms (POF4-352) (POF4-352)
  3. 351 - Brain Function (POF4-351) (POF4-351)
Experiment(s):
  1. Longitudinal Cognitive Impairment and Dementia Study

Appears in the scientific report 2023
Database coverage:
Medline ; Creative Commons Attribution CC BY 4.0 ; DOAJ ; OpenAccess ; Article Processing Charges ; Clarivate Analytics Master Journal List ; Current Contents - Clinical Medicine ; DOAJ Seal ; Ebsco Academic Search ; Essential Science Indicators ; Fees ; IF >= 5 ; JCR ; PubMed Central ; SCOPUS ; Science Citation Index Expanded ; Web of Science Core Collection
Click to display QR Code for this record

The record appears in these collections:
Institute Collections > BN DZNE > BN DZNE-Clinical Research Platform (CRP)
Institute Collections > MD DZNE > MD DZNE-Core Technical Staff (Magdeburg)
Institute Collections > BN DZNE > BN DZNE-Patient Studies (Bonn)
Document types > Articles > Journal Article
Institute Collections > GÖ DZNE > GÖ DZNE-AG Wiltfang
Institute Collections > BN DZNE > BN DZNE-AG Schneider
Institute Collections > GÖ DZNE > GÖ DZNE-AG Fischer
Institute Collections > ROS DZNE > ROS DZNE-AG Teipel
Institute Collections > TÜ DZNE > TÜ DZNE-AG Jucker
Institute Collections > TÜ DZNE > TÜ DZNE-AG Gasser
Institute Collections > BN DZNE > BN DZNE-AG Jessen
Institute Collections > MD DZNE > MD DZNE-AG Düzel
Institute Collections > BN DZNE > BN DZNE-AG Wagner
Institute Collections > BN DZNE > BN DZNE-AG Heneka
Institute Collections > BN DZNE > BN DZNE-Biomarker
Institute Collections > M DZNE > M DZNE-AG Dichgans
Institute Collections > MD DZNE > MD DZNE-AG Maaß
Institute Collections > B DZNE > B DZNE-AG Priller
Institute Collections > B DZNE > B DZNE-AG Dirnagl
Institute Collections > M DZNE > M DZNE-AG Simons
Institute Collections > BN DZNE > BN DZNE-AG Latz
Institute Collections > B DZNE > B DZNE-AG Endres
Institute Collections > M DZNE > M DZNE-Delcode
Full Text Collection
Public records
Publications Database

 Record created 2023-01-16, last modified 2024-08-26